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There are 100 times more virions than eukaryotic cells in a healthy human body. The characterization
of human-associated viral communities in a non-pathological state and the detection of viral pathogens
in cases of infection are essential for medical care and epidemic surveillance. Viral metagenomics, the
sequenced-based analysis of the complete collection of viral genomes directly isolated from an
organism or an ecosystem, bypasses the ‘‘single-organism-level’’ point of view of clinical diagnostics
and thus the need to isolate and culture the targeted organism. The ﬁrst part of this review is dedicated
to a presentation of past research in viral metagenomics with an emphasis on human-associated viral
communities (eukaryotic viruses and bacteriophages). In the second part, we review more precisely the
computational challenges posed by the analysis of viral metagenomes, and we illustrate the problem
of sequences that do not have homologs in public databases and the possible approaches to
characterize them.
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Viral infections may become more prevalent in the future as
multiple factors contribute to the emergence of new viral patho-
gens (Delwart, 2007; Wang, 2011). The expansion of the human
population has led to the removal of barriers between animal and
human communities, which favors the development of zoonoses.
In addition, modern immunosuppressive therapies create favor-
able environments for the replication of viruses that are not
commonly pathogenic. Furthermore, the spread of viruses world-
wide is promoted by globalization and climate change, which
extend the active ranges for some viral vectors, and there still
exist several common pathologies, such as encephalitis and many
respiratory syndromes, for which extensive classical diagnostic
testing has failed to determine the etiology and which are thought
to be of viral origin (Glaser et al., 2003; Quan et al., 2007).
Thus, an improved detection of newly emerging and re-emerging
viruses and a systematic characterization of the full range of viruses
that infect humans are needed (Anderson et al., 2003).
Classical methods of viral detection have several limitations.
First, most of them are based on isolation and culture of the viral
pathogen, but frequently the virus or its host cannot be cultivated
under laboratory conditions, or the virus does not exhibit its
characteristic cytopathic effects in culture (Specter, 1992). Moreover,
these methods target known agents, and they are thus unsuitable
for the detection of unexpected pathological agents or for the
discovery of new ones. Immunological assays, for example, fail to
identify unexpected or unknown viruses because such viruses are
usually too divergent to cross-react. With respect to molecular tools,
viruses lack a universally conserved genetic marker to target, and
PCR assays directed towards conserved sequences within viral
groups can only identify close variants of those groups (Staheli
et al., 2011; Rose et al., 1998). Although the use of a wide set of
different and highly degenerate primers has allowed the identiﬁca-
tion of numerous viruses (Culley et al., 2003), it does not allow a
systematic and comprehensive screening to determine the identity
of every virus that may be present.
Viral metagenomics and its ﬁrst applications
Metagenomics, which is commonly deﬁned as the sequenced-
based analysis of the whole collection of genomes directly isolated
from a sample (Handelsman et al., 1998), overcomes the principal
limitations of the classical tools for viral detection. In fact, unlike
traditional techniques for microbial and viral identiﬁcation, metage-
nomics does not require prior isolation and clonal culturing for
species characterization, nor does it rely on previous assumptions
about what organisms are expected to be present or the genomic
sequences that are to be targeted. Thus, it is particularly suitable to
provide a global overview of the community diversity (species
richness and distribution) and functional (metabolic) potential and
to identify new species. In principle, it allows the identiﬁcation of any
organism, including those commonly not detected because they are
difﬁcult to isolate and grow under laboratory conditions. Such
organisms are estimated to constitute between 90% and 99% of
microbial species (Rappe´ and Giovannoni, 2003; Pace, 1997). Indeed
the method of viral isolation, library preparation and sequencing
affects the type of viruses which are retrieved. These issues have to be
considered when analyzing the taxonomical proﬁle of a metagenome
and will be discussed later (see ‘‘General considerations on technical
issues and potential biases in metagenome preparation’’).
Metagenomics has a wide variety of applications from ecology
and environmental sciences (Breitbart et al., 2002; Dinsdale et al.,
2008) to the chemical industry (Lorenz and Eck, 2005) and human
health (Turnbaugh et al., 2007; Ravel et al., 2010; Sullivan et al.,
2011; Nakamura et al., 2009; Minot et al., 2011). Historically, itwas ﬁrst associated with the study of uncultured microbial
organisms (bacteria and archaea) in environmental samples
(Handelsman et al., 1998; Hugenholtz and Tyson, 2008). More
recently, it has also been applied to the characterization of viral
communities, a task that it is particularly suited for because the
small size of viral genomes makes their coverage more compre-
hensive using the same number of metagenomic sequences. The
ﬁrst example of viral metagenomics was performed by Breitbart
et al. in 2002. This study revealed that viral diversity had been
widely underestimated because, in approximately 200 l of marine
water, more than 7000 different viral genotypes were found. This
high degree of viral genetic diversity has been conﬁrmed by
further metagenomic studies of marine water (Angly et al., 2006),
marine sediments (Breitbart et al., 2004) and freshwater (Lopez-
Bueno et al., 2009). Today, viruses are considered the most
abundant and diverse living forms on earth (Culley et al., 2006;
Suttle, 2005). Their diversity has been explored by metagenomics
in a wide variety of environments: oceans (Williamson et al.,
2008), stromatolites (Desnues et al., 2008), acidic hot springs
(Rice et al., 2001), and subterranean and hypersaline environ-
ments (Dinsdale et al., 2008).
Identifying human-associated viral communities (the human virome)
A preliminary step in identifying viral agents that cause
disease is the characterization of the viral microﬂora associated
with humans in a non-pathological state. To date, only a few viral
metagenomic studies have been performed on human samples.
Moreover, due to the limited availability and size of human
samples, most of these studies used fecal samples (Reyes et al.,
2010; Breitbart et al., 2008,2003; Minot et al., 2011,2012; Zhang
et al., 2006; Kim et al., 2011).
The ﬁrst contribution to the assessment of the human virome
by metagenomics was made in 2003 by Breitbart et al. who
studied the DNA virus community that was associated with the
human gut through partial shotgun sequencing of the feces of a
healthy adult. Most of the sequences generated were unknown
(59% according to a tblastx search against the Genbank non-
redundant database with an E-valueo1e03). Among the iden-
tiﬁable viral sequences, the majority were phages (Breitbart et al.,
2003). The community was estimated to have a high richness
(approximately 1200 different genotypes) and diversity as esti-
mated by the Shannon–Wiener index (H0 ¼6.4 nats) which deter-
mines species diversity on the basis of both the number of species
and the relative contribution of each of these species to the total
number of individuals in a community. Breitbart et al. performed
an analogous study in 2008 using the feces of a 1-week-old infant.
Similarly to the 2003 study, an elevated percentage of unknown
sequences (66%) and a signiﬁcant abundance of phages were
found. Similar observations were also reported by two recent
studies on the DNA virome of the human gut (Reyes et al., 2010;
Minot et al., 2011) in which the percentage of unknown
sequences was 81% and 98%, respectively, and phages dominated
the viral community. However, the richness and diversity of these
viral communities were signiﬁcantly lower in comparison with
the results obtained by Breitbart in 2003 and in particular to the
1-week-old infant, whose virome richness was 8 genotypes and
whose Shannon–Wiener index was only 1.63 nats. In addition to
the DNA viruses, the RNA viruses of the human gut have also been
studied (Zhang et al., 2006; Nakamura et al., 2009). In a study
performed using stool samples from two healthy adults, Zhang
et al. found that only 8.9% of the sequences were unknown
(tblastx search with Eo1e03) and that among the identiﬁable
viral sequences there was an insigniﬁcant number of phages.
The majority of the identiﬁable viruses were plant viruses (91.5%).
Among these viruses, they found viruses that infect consumable
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consumption of contaminated produces. They also observed that
the viral community was dynamic and that it changed substan-
tially in the same individual over time (Zhang et al., 2006).
Few other body sites have been targeted by viral metagenomics.
In 2005, Breitbart and Rohwer analyzed the DNA virus communities
associated with blood samples from healthy donors, and they were
able to recover sequences from a novel anellovirus whose presence in
the general population was then conﬁrmed by speciﬁc PCR on a pool
of 100 blood donors (Breitbart and Rohwer, 2005). In 2010, Willner
et al. analyzed the DNA virus community of the human oral cavity
using oropharyngeal swabs and showed that it was dominated by
phages; the only eukaryotic virus detected was Epstein–Barr virus
(Willner et al., 2010). A comparative study between patients affected
by cystic ﬁbrosis and healthy individuals showed that, in a non-
disease state, the DNA virus community populating the sputum,
which should be representative of the human respiratory tract, was
again dominated by phages; among the eukaryotic viruses detected
were adenoviruses, herpesviruses and poxviruses (Willner et al.,
2009). Moreover, different individuals presented different viral
communities, which likely were representative of a random sample
of the inhaled organisms from the exterior environment; these viral
particles are thought to establish transient infections that are rapidly
cleared by the immune system or to be simply removed from the
airway by mucociliary clearance. Interestingly, these communities
were transient from a taxonomic point of view but constant with
respect to the metabolic functions encoded. The estimated richness
was 243 different genotypes, and the diversity, as measured by the
Shannon–Wiener index, was as low as 4.83 nats.
A human salivary virome has also been described (Pride et al.,
2011). Saliva samples from ﬁve healthy human subjects were
studied over a 2- to 3-month period. The viral communities were
dominated by bacteriophages, in contrast to the communities
from human stool samples or the respiratory tract, and were
likely the result of environmental inﬂuences. More than 122
thousands of homologs to genes involved in bacterial pathogeni-
city were identiﬁed in the salivary virome. This suggests that the
bacteriophages contained in the saliva may serve as a reservoir of
virulence-associated genes in the human oral environment.
Today, the assessment of the human virome in the non-disease
state is still widely incomplete. Viral metagenomic studies character-
izing the common ‘‘viral ﬂora’’ associated with humans in the non-
disease state need to be continued because they constitute a
reference point in viral metagenomic clinical investigations. Indeed,
they provide a baseline against which clinical samples can be
compared to identify novel or divergent human viruses and assess
which viruses are potentially responsible for idiopathic human
diseases.
Bacteriophages in the human virome
Metagenomic studies aimed at characterizing the human
virome have noted the prevalence and ubiquity of bacteriophages
(viruses of bacteria) in humans. The vast majority of human
viruses recovered by metagenomics were identiﬁed as viruses of
bacteria, as shown in salivary (Pride et al., 2011), respiratory tract
(Willner et al., 2009), gastrointestinal tract (Reyes et al., 2010)
and oropharyngeal samples (Willner et al., 2010).
It is estimated that approximately 1013 to 1015 bacteriophages
populate the human body (Haynes and Rohwer, 2011). These
bacteriophages may have a substantial role in shaping and
regulating human bacterial communities through lysis and hor-
izontal gene transfer; a similar role has already been shown in
environmental bacterial communities (Letarov and Kulikov, 2009;
Weinbauer, 2004; Breitbart et al., 2004). Thus, they are also
thought to be able to inﬂuence healthy and diseasestates in humans by, for example, eradicating certain bacteria
or by conferring on bacteria a new pathogenic phenotype
(Breitbart and Rohwer, 2005). Metagenomic analysis of viral
communities populating the human oropharynx has suggested
that bacteriophages are important reservoirs of virulence genes,
such as the platelet-binding factors pblA and pblB, for oropharyngeal
bacteria. Moreover, considerable differences were observed in the
human respiratory tract between the bacteriophage communities
associated with healthy subjects and the communities of cystic
ﬁbrosis patients (Willner et al., 2009). Antibiotic resistance genes
were also found in bacteriophages colonizing cystic ﬁbrosis patients,
which could be passed through horizontal gene transfer to other
bacterial communities and make those bacteria resistant. This
phenomenon may represent a potential new therapeutic target
to prevent the emergence of multidrug-resistant bacteria, which
is a major problem in the treatment of cystic ﬁbrosis patients
(Fancello et al., 2011).
Clinical applications: discovery of human pathogens
The ﬁrst application of viral metagenomics to human clinical
research was in 2008 when Palacios et al. used the 454/Roche
pyrosequencing platform to detect the pathogen responsible for a
cluster of fatal transplant-associated diseases and identiﬁed a
new arenavirus that was transmitted through solid-organ trans-
plantation (Palacios et al., 2008). Since that initial study, viral
metagenomics has led to the discovery of other previously
unknown and potentially pathogenic viruses in stool samples
(Victoria et al., 2009; Sullivan et al., 2011; Finkbeiner et al., 2008;
Holtz et al., 2008), nasopharyngeal aspirates (Allander et al.,
2005), serum/blood samples (Sullivan et al., 2011; Briese et al.,
2009; McMullan et al., 2012) and a frontal lobe biopsy (Quan,
2010) collected from patients affected by idiopathic diseases. An
overview of viral metagenomics studies on human clinical sam-
ples is provided in Table 1.
The interest in applying viral metagenomics to human patients
comes not only from its capacity to identify new viruses that
could potentially be implicated in a targeted disease but also from
its capacity to conﬁrm the presence of known pathogenic viruses
even at concentrations lower than the levels detectable by PCR
(Nakamura et al., 2009). Moreover, metagenomics can also high-
light unexpected tropisms of known viruses and the potential
pathogenicity of known viruses that are not suspected in the
studied disease and thus are not targeted by standard diagnostic
tests. An example is the implication of yellow fever virus in the
hemorrhagic fever outbreak in October, 2010, in Uganda
(McMullan et al., 2012). Also in 2010, Greninger et al. demon-
strated that metagenomics was an efﬁcient approach to rapidly
identify and characterize the full genome of a ﬂu virus without a
priori information (Greninger et al., 2010). Clinical applications of
viral metagenomics can also give important clues about which
therapeutic measures to develop. For example, the metagenomic
study of the viral communities populating human lungs in cystic
ﬁbrosis patients and healthy controls revealed that the diseased
and non-diseased states are deﬁned by their metabolic, rather
than phylogenetic, proﬁles. Thus, therapeutic measures may be
more effective if directed at changing the respiratory environ-
ment rather than targeting the dominant taxa (Willner et al.,
2009, 2010).
General considerations on technical issues and potential biases
in metagenome preparation
The way a viral metagenome is generated can widely affect the
type of viruses retrieved and it should be taken into consideration
for downstream analyses. Most of the biases related to
Table 1
Viral metagenomic studies on human samples for clinical application. Targeted disease, nucleic acids type (DNA or RNA viral genomes), sample type, eventual discovery of
new viruses and sequencing technology are reported, as well as the method of viral particles isolation and the computational tools used for assembly and annotation.
Targeted
disease
Nucleic
acid
Samples New virus discovered Sequencing
method
Viral particles
isolation
Assembly Annotation Reference
Lower
respiratory
tract infection
DNA
RNA
Nasopharyngeal
aspirates
Parvovirus, coronavirus Sanger Ultracentrifugation;
0.22 mm ﬁltering
Not performed BLAST (Allander
et al., 2005)
Human merkel
cell carcinoma
RNA Cell carcinoma
tissues
(biopsies)
Polyomavirus 454/Roche (Direct nucleic acids
extraction)
Not performed BLAST (Feng et al.,
2008)
Diarrhea RNA Stool Astrovirus, torque teno
virus, norovirus,
picobirnavirus, enterovirus,
nodavirus
Sanger Centrifugation;
0.45 mm ﬁltering
Not performed BLAST (Finkbeiner
et al., 2008)
Acute
respiratory
infections and
diarrhea
RNA Nasopharyngeal
aspirates, stool
– 454/Roche Centrifugation Not performed BLAST, SSEARCH (Nakamura
et al., 2009)
Fatal transplant-
associated
disease
RNA Brain,
cerebrospinal
ﬂuid, serum,
kidney, liver
Arenavirus 454/Roche (Direct nucleic acids
extraction)
CAP3 (Huang and
Madan. 1999)
BLAST (Palacios
et al., 2008)
Hemorragic
fever
RNA Liver biopsies,
serum
Arenavirus 454/Roche (direct Nucleic acids
extraction)
GCG Package
(Accelrys, San Diego,
CA, USA)
CLC RNA
Workbench (CLC
bio, A˚rhus,
Denmark)
(Briese
et al., 2009)
Acute ﬂaccid
paralysis
DNA Stool Bocavirus, picornaviruses,
circovirus, nodavirus,
dicistroviruses
454/Roche,
Sanger
Centrifugation;
0.45mm ﬁltering
Sequencher (Gene
Codes Corporation,
Ann Arbor, MI USA)
BLAST (Victoria
et al., 2009)
Cystic ﬁbrosis DNA Sputum – 454/Roche 0.45 mm ﬁltering;
CsCl gradient
PHRAP (www.phrap.
org)
BLAST, MG-RAST (Willner
et al., 2009)
Upper
respiratory
tract infection
RNA Nasopharyngeal
aspirates
– Illumina (Direct nucleic acids
extraction)
Geneious (http://
www.geneious.com)
BLAST (Greinger
et al., 2010)
Encephalitis RNA Frontal cortex
(biopsy)
Astrovirus 454/Roche (Direct nucleic acids
extraction)
GreenPortal website
(http://tako.cpmc.
columbia.edu/Tools)
BLAST (Quan,
2010)
Chronic fatigue
syndrome
DNA
RNA
Serum – 454/Roche,
Sanger
0.22 mm/0.45 mm
ﬁltering;
ultracentrifugation
miraEST (Chevreux
et al., 2004)
BLAST (Sullivan
et al., 2011)
Acute
exacerbation
of idiopathic
pulmonary
ﬁbrosis
RNA Bronchoalveolar
lavage and
serum
– Illumina (Direct nucleic acids
extraction)
Not performed MegaBLAST,
BLAST
(Wootton
et al., 2011)
Lower
respiratory
tract
infections
DNA &
RNA
Nasopharyngeal
aspirates
Rhinovirus C 454/Roche 0.22 mm/0.45 mm
ﬁltering;
ultracentrifugation
miraEST (Chevreux
et al., 2004)
MegaBLAST,
BLAST
(Lysholm
et al., 2012)
Hemorragic
fever
RNA Serum – 454/Roche (Direct nucleic acids
extraction)
Newbler (Roche);
CLC (CLC bio,
Aarhus, Denmark)
BLAST, MEGAN (McMullan
et al., 2012)
Cystic ﬁbrosis DNA Lung tissue
(biopsies)
– 454/Roche 0.45 mm ﬁltering;
CsCl gradient
CAP3 (Huang and
Madan, 1999)
BLAST (Willner
et al., 2011)
Tropical febrile
illness
DNA
RNA
Serum Circovirus Illumina (Direct nucleic acids
extraction)
Not performed BLAST (Yozwiak
et al., 2012)
L. Fancello et al. / Virology 434 (2012) 162–174 165metagenome preparation have already been discussed elsewhere
(Morgan et al., 2010; Thomas et al., 2012). Here, we will brieﬂy
resume potential biased related to viral particles isolation, nucleic
acid ampliﬁcation and the sequencing technology used.
Viral particle isolation is usually performed by a combination
of ﬁltration and/or (ultra)centrifugation. Viral particles can be
further puriﬁed onto a cesium chloride density gradient (Thurber
et al., 2009). Sample ﬁltering is often necessary to eliminate
contamination by host cells and other non-viral cells. Because
viral genomes generally are shorter than those of their eukaryotic
or prokaryotic hosts, a minimal contamination would result in the
preferential sequencing of those longer genomes which would
‘‘mask’’ viral sequences. However, most environmental metage-
nomic studies ﬁlter samples at 0.2 mm, which does not allow
recovering large viruses and thus introduces a bias in theresulting metagenome taxonomic composition as already pointed
out elsewhere (Thurber et al., 2009).
Another issue in metagenomes preparation is the need of a
nucleic acids ampliﬁcation step before sequencing as a result of
the small amount of nucleic acids extracted from isolated viral
particles. This is particularly critical for human-associated viral
metagenomes as the volume of available sample may be more
limited than in environmental studies. Nucleic acids may be
ampliﬁed using the LASL (Linker Ampliﬁed Shotgun Library)
method where the viral DNA (or the cDNA obtained from viral
RNA genomes) is fragmented, ligated with an adapter and PCR
ampliﬁed with a single primer speciﬁc to the adapter (Breitbart
et al., 2002). Because the adapter ligation is only possible for
dsDNA fragments, ssDNA viral genomes are not ampliﬁed and
cannot be recovered in the metagenome (Kim and Bae, 2011).
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ﬁcation (MDA), i.e. the isothermal ampliﬁcation of the DNA (or
the cDNA obtained from viral RNA genomes) by using random
hexamers and the phi29 DNA polymerase. MDA is known to
amplify more efﬁciently small circular DNA than linear DNA and
preferentially ssDNA rather than dsDNA (Kim and Bae, 2011; Kim
et al., 2011). It may also generate chimeras (Lasken and Stockwell,
2007) and introduce quantitative biases (Yilmaz et al., 2010). As
different protocols can give different views on the diversity of the
viral community studied, the biases introduced in the metagen-
ome preparation have to be considered in downstream analyses
and further comparative metagenomics.Computational tools and algorithms in clinical viral
metagenomics
One of the hardest challenges in metagenomic studies is
sequence analysis, particularly because there is a large amount
of data. For this reason, bioinformatics is essential to extract
meaningful information from metagenomes. Computational ana-
lysis of metagenomes is particularly challenging in the case of
viral community surveys. Viruses have an extremely high muta-
tion rate, and they can be highly divergent, which hampers the
identiﬁcation of known homologs using similarity searches. In
addition, viruses may exist in a proviral form, which complicates
the task of distinguishing viral genomic sequences from host
sequences. In the workﬂow for the analysis of a viral metagen-
ome, the principal steps, aside from quality processing of rawFig. 1. Overview of the main issues and tools for computational analysis in genomics, m
we reported speciﬁc issues, if any, relative to (non viral) metagenomic and viral metagreads, address the taxonomical and functional characterization of
metagenomes, the gene prediction, the (partial) assembly of the
genomes, the characterization of the community structure and
diversity and comparisons of metagenomes. Due to the earlier
and wider expansion of bacterial metagenomics over viral meta-
genomics, the ﬁrst tools developed in this ﬁeld were designed for
the analysis of bacterial communities (Kunin et al., 2008; Wooley
and Ye, 2010; Raes et al., 2007; Wooley et al., 2010) and may be
unsuitable for the analysis of viral communities (see Fig. 1). The
following sections present the computational tools and algo-
rithms commonly used in viral metagenomics, with speciﬁc
attention paid to clinical research.Pre-processing and quality control
A typical metagenomic data workﬂow begins with quality
control and the pre-processing of the raw reads produced by
high-throughput sequencing technologies. The main goal is to
create a high-quality metagenomic dataset that is faithfully
representative of the genotypes present in the sample and of
their relative abundances. Quality control includes the investiga-
tion of length, GC content, quality score, number of ambiguous
bases ‘‘N’’ and the sequence complexity distribution of the reads.
The criteria and methods for quality control are highly dependent
on the sequencing technology used. These are general issues for
all kinds of studies using data from high-throughput sequencing
technologies and therefore are not the object of this review.
Instead, we will treat here another pre-processing issue which
is speciﬁc to metagenomics and in particular viral metagenomics:etagenomics and viral metagenomics. For each step of the computational analysis,
enomics. Corresponding computational tools are reported in italic.
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Filtering should be performed to obtain a metagenome that only
contains sequences of interest (i.e., viral sequences). Filtering step
limits misassemblies, and the resulting reduced size of the dataset
speeds up the downstream analysis. There are two main sources
of contamination: (i) primers and their eventual concatenations
that are produced when metagenomes are generated by pre-
ampliﬁcation with primer-based methods (e.g., RNA virus com-
munities generated by a Whole Transcriptome Ampliﬁcation
approach); and (ii) genomic material from organisms present in
the sample that are not the targets of the metagenomic survey
(e.g., host eukaryotic cells or prokaryotic material when the viral
community is being studied). To eliminate contaminating pri-
mers, TagCleaner (Schmieder et al., 2010) and TagDust (Lassmann
et al., 2009) can be used on 454/Roche- and Illumina-generated
sequences, respectively. Contamination from genomic material
can be removed after a BLAST search of all the reads that match
with the genomes of the contaminating organisms; this task is
automated by DeconSeq (Schmieder and Edwards, 2011). Recent
studies have shown that viral metagenomes generated from
human samples may contain over 90% host-derived sequences
when nucleic acids are isolated without prior elimination of host
or bacterial cells (Nakamura et al., 2009). Contamination from
host genomic material can still represent a serious concern even
in protocols that have been optimized to remove host and
bacterial cells. For example, in a study by Willner et al., the
percentage of human-derived sequences could be as high as 34%
(Willner et al., 2009), although their protocol included a ﬁltration
step at 0.45 mm and a viral particle puriﬁcation step using a
cesium chloride gradient.
Human viral metagenomes are frequently dominated by
sequences annotated as bacteria (Edwards and Rohwer, 2005;
Rosario and Breitbart, 2011). Annotation and removal of bacterial-
annotated reads must be carefully evaluated, as part of these
might come from genes of bacterial origin transferred to their
phages (Beumer and Robinson, 2005; Ghosh et al., 2008) or from
excised prophages mistakenly annotated as bacteria. Recently, it
has been proposed that the extensive presence of bacterial-like
genes in viral metagenomes could be due to the presence of Gene-
Transfer Agents (GTA) (Kristensen et al., 2010). These are phage-
like particles found in a wide range of prokaryotes which are able
to mediate gene transfers (Lang et al., 2012). Although similar to
transducing bacteriophages, their production by a cell does not
result from a phage infection, the amount of DNA packaged in
GTAs is insufﬁcient to encode the protein components of the
particle itself and it contains a random piece of the genome of the
producing cell. So far, the proportion of GTAs in viral metagen-
omes is unknown and the reason for such a large number of
bacterial sequences retrieved from viral metagenomes is not clear
(Lang et al., 2012).
Annotation, assembly and estimation of the community diversity
and structure
Taxonomic identiﬁcation, i.e., the assignment of each sequence to
the genome from which it was generated, is one of the main goals of
metagenomic studies. Indeed, it is a difﬁcult task, especially for reads
produced by high-throughput sequencing technologies that are only
50–500 nucleotides. Because of their short lengths, these reads are
less informative and can be difﬁcult to classify. An assembly step
introduced prior the taxonomic classiﬁcation could thus be very
helpful by providing a better accuracy and sensitivity in the sequence
assignments. At the same time, assembly itself constitutes a challenge
in metagenomic studies which may be simpliﬁed by previous binning
of sequences according to their putative taxonomic assignment
(Garcı´a Martı´n et al., 2006; Woyke et al., 2006). Taxonomicassignment and assembly, although described separately in the
following sections, are deeply intertwined.Taxonomic classiﬁcation
Taxonomic classiﬁcation is currently one of the most active
ﬁelds in metagenomics. Several approaches have been developed
and can be principally classiﬁed as either ‘‘similarity-based’’
methods or ‘‘composition-based’’ methods.
Similarity-based methods are most frequently used to describe
the taxonomic proﬁle of viral metagenomes. They are usually based
on BLAST searches (Altschul et al., 1990), although other useful
algorithms exist, including FAAST, which uses pyrosequencing
ﬂowpeak information to improve the alignment accuracy (Lysholm
et al., 2011), or BLAT (Kent, 2002). Because most metagenomic
sequences belong to unknown organisms, searches based on strin-
gent E-values can yield too few classiﬁable sequences. In contrast,
less stringent E-values can result in a high number of incorrect
assignments. Thus, a few similarity-based taxonomic classiﬁers have
been developed to evaluate taxonomic assignments that are based
on alignment parameters. One of the most frequently used is
MEGAN (Huson et al., 2007), a rank-ﬂexible taxonomic classiﬁer,
i.e., a classiﬁer that attempts to assign reads to the most appropriate
taxonomic level when lacking sufﬁcient phylogenetic information
without forcing them to a particular rank to avoid misclassiﬁcation
of ambiguous reads. Although MEGAN has been adopted for viral
metagenomic analysis (Kim et al., 2011; Yang et al., 2011), it was not
speciﬁcally developed for this task. Conversely, ProViDE (Program
for Viral Diversity Estimation) is a software tool based on a set of
alignment parameter thresholds that are speciﬁc for viral metage-
nomic analysis (Ghosh et al., 2011). These thresholds take into
account the patterns of sequence divergence and the non-uniform
taxonomic hierarchies observed within/across viral taxonomic
groups to increase the percentage of correct taxonomic assignments.
Several biases affect the performance of similarity-based taxonomic
classiﬁcation methods. First, the content of public sequence data-
bases is incomplete and only poorly reﬂects the existing biological
diversity (McHardy and Rigoutsos, 2007). This is especially true in
the viral world, which is mostly unknown; the majority of
sequences obtained from viral metagenome projects has no homol-
ogy to previously described sequences stored in public databases
(Edwards and Rohwer, 2005) and cannot be classiﬁed by similarity
searches. Moreover, viruses have high genetic diversity and diver-
gence, which limits the probability of ﬁnding remote similarities
between unknown and known viruses. Indeed, BLASTx, rather than
BLASTn, searches are suggested for the classiﬁcation of metage-
nomic sequences (Kunin et al., 2008). Because synonymous muta-
tions are bypassed in the translation step, this method is more
sensitive for recovering remote similarities. Additionally, the short
lengths of metagenomic sequences can make reaching statistical
signiﬁcance in similarity searches difﬁcult; prior assembly into
longer sequences (called contigs) can thus be helpful in the
taxonomic analysis. Finally, another drawback of these methods is
that they are extremely time consuming.
Composition-based methods are taxonomic classiﬁcation meth-
ods that are based on nucleotide composition. They are computa-
tionally faster than similarity-basedmethods, and they are useful for
the classiﬁcation of sequences that are highly divergent from the
sequences in public databases. However, they depend on read length
and have lower accuracy than similarity-based methods. They start
from the assumption that the genome sequence composition varies
among different organisms. Indeed, sequence composition is driven
by taxonomy-related forces, such as the translational selection
exerted on the synonymous codon usage of coding sequences, the
polymerase nucleotide incorporation biases, the context-dependent
mutation pressures and the optimal growth temperature of the
L. Fancello et al. / Virology 434 (2012) 162–174168organism (Karlin et al., 1997,1994; Perry and Beiko, 2010;
Deschavanne et al., 1999). Genomic sequence composition has been
shown to be sufﬁciently organism-speciﬁc to allow discrimination
among several species (Kariin and Burge., 1995; Karlin et al., 1997)
and thus to be employed for taxonomic classiﬁcation. In addition, in
the study by Teeling et al., the GC content and tetranucleotide
signatures were adapted for the taxonomic classiﬁcation of
sequences from bacterial soil metagenomes (Teeling et al., 2004a).
One of the ﬁrst composition-based taxonomic methods, the TETRA
software, is based on the computation of tetranucleotide usage
patterns and performs comparisons with pre-computed patterns
from organisms in a reference dataset (Teeling et al., 2004b).
Unfortunately, this reference dataset does not contain viral gen-
omes, and comparisons are not yet possible for viral metagenomes.
More recently, programs based on the oligonucleotide composition
of variable-length genome fragments have also been developed to
achieve higher accuracy and sensitivity, including PhyloPythia
(McHardy et al., 2007) and Phymm (Brady and Salzberg, 2011);
other programs have been speciﬁcally developed to work correctly
with metagenomes that exhibit both even and highly uneven
species abundance distributions, e.g., Metacluster 3.0 (Leung et al.,
2011) and Metacluster 4.0 (Wang et al., 2012). Finally, there are
hybrid methods that combine similarity-based and composition-
based approaches, including SPHINX (Mohammed et al., 2011) and
PhymmBL (Brady and Salzberg, 2011). However, all of these meth-
ods are not suitable for viral metagenomes analysis because they are
not trained or benchmarked on viral genomes. To our knowledge,
the only composition-based tool speciﬁcally suited to predict the
taxonomy of viral metagenomic sequences is MGTAXA (http://
mgtaxa.jcvi.org), which was developed at the J. Craig Venter
Institute and is freely available on the galaxy platform (http://
galaxyproject.org). Based on Phymm, it is trained on viral genomes
as well. Although composition-based methods have mostly been
used for bacterial metagenomes, this approach has already been
successfully tested on viral sequence classiﬁcations (Trifonov and
Rabadan, 2010; Willner et al., 2009). Moreover, nucleotide composi-
tion analysis can also be used to infer the potential hosts of
uncharacterized viral sequences. Indeed, the genome nucleotide
composition of a virus is inﬂuenced by its host because it depends
on the host for its replication (Kapoor et al., 2010). However, the
compositional similarity between bacteriophage genomes and their
hosts’ genomes can be a confounding factor in the classiﬁcation task.
Therefore, the application of composition-based classiﬁcation meth-
ods to viral metagenomes is a promising ﬁeld of research, but
further efforts in this area are needed.Assembly
Assembly of metagenomic data is a complicated task due to the
following factors: (i) the presence of several different genomes;
(ii) non-species-speciﬁc contigs; (iii) conserved genomic regions that
are shared between distantly related species; iv) the high frequency
of polymorphisms and genome variation even at the subspecies
level; (v) repeated regions; and (vi) the different coverages across
species due to uneven species frequencies in the sample. The
extreme richness and complexity of an environmental metagenomic
sample and the limited depth of sequencing make virtually impos-
sible to assemble all the individual genomes of a metagenomic
project. However, it can be possible to reconstruct the genome(s) of
the dominant species in the case of a highly uneven community.
This is particularly true for viruses due to their shorter genome
lengths. Such scenarios are of particular interest in metagenomics
that is applied to clinical research because viral infection is expected
to produce high viral loads of one dominant viral genotype over
other residual viruses. Other interests of assembly are an improved
length of assembled contigs compared to unassembled reads, whichfacilitates the taxonomic assignment and increases its accuracy in
case of ambiguous reads. Moreover assembly may provide full-
length coding sequences for subsequent analyses. Finally, assembly
reduces the volume of the dataset and therefore the processing
requirements.
So far, most studies have used de novo assemblers developed
for single genome sequencing. The choice of assemblers
depends on the average read length of the dataset, thus on the
sequencing technology used. Phrap (http://www.phrap.org), Ara-
chne (Batzoglou et al., 2002) and JAZZ (Aparicio et al., 2002) were
for example used for Sanger-generated reads. Following the
development of next-generation sequencing technologies and
their application to metagenomic studies new versions of these
de novo assembly tools and completely new algorithms were
implemented to deal with the high throughput short reads
generated by these technologies. Most of the new algorithms
were based on the ‘‘de Bruijn graph’’ approach. Euler (Pevzner
et al., 2001), ALLPATH (Butler et al., 2008), Velvet (Zerbino and
Birney, 2008), SOAPdenovo (Li et al., 2009) and AbySS (Simpson
et al., 2009) were initially developed for very short reads
(o100 bp). The commercial assembler Newbler was implemen-
ted by Roche to speciﬁcally assemble 454-generated reads. For
more information about these and further single genome NGS
assemblers we address the reader to a speciﬁc review on this
subject (Miller et al., 2010).
Still these assemblers were not speciﬁcally designed for metagen-
omes assembly. Some strategies had been adopted to make classic
assemblers suitable for the analysis of metagenomic data, including
the use of reference sequences (Rusch et al., 2007) and the pre-
binning of reads on the basis of their sequence composition, which
should be suggestive of their taxonomic classiﬁcation (Garcı´a Martı´n
et al., 2006; Woyke et al., 2006). These methods may be affected by
errors and may produce fragmented assemblies, hampering down-
stream analysis. These limits have been highlighted on simulated
metagenomes (Pignatelli and Moya, 2011; Mavromatis et al., 2007).
More recently, new assembly algorithms have been imple-
mented that speciﬁcally address the metagenome assembly
problems. Genovo, for example, is an assembler based on the
construction of a Bayesian probabilistic model of read generation
from metagenomic samples, and it functions by discovering likely
sequence reconstructions under this model (Laserson et al., 2011).
Another approach is the assembly of translated ORFs rather than
raw reads. This method, implemented by MetaORFA (Ye and Tang,
2009), simpliﬁes the assembly task because it eliminates repeated
regions (which are much more frequent in non-coding DNA than
in ORFs) and thus avoids chimeric contigs. The assembly
of sequences with synonymous mutations can also be easier
because these mutations do not appear at the amino acid level,
i.e., in translated ORFs. A further advantage is that downstream
homology searches on longer peptide sequences assembled from
ORFs are more sensitive and speciﬁc than searches using raw
reads or single ORFs identiﬁed in an individual read. Another
metagenome-speciﬁc assembler is Meta-IDB, which is not only
capable of reconstructing longer contigs but also provides multi-
ple alignments of similar contigs from different subspecies
(variants) of the same species (Peng et al., 2011). Longer contigs
can be produced because of two of the program’s strengths: (i) its
efﬁciency in eliminating genomic regions that are common to
multiple species, thus isolating species that are different from
each other; and (ii) its capacity to produce a unique consensus for
different variants of the same subspecies instead of different
contigs. Variations of this consensus are then represented by a
multiple sequence alignment. Similarly to Meta-IDB (Peng et al.,
2011), MetaVelvet (Namiki et al., 2012) and Bambus2 (Koren
et al., 2011) focus on the detection of genomic repeats, which can
generate chimeric sequences, and on the detection of
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contigs that represent different variants of the same subspecies
(Koren et al., 2011). Moreover, Bambus2 is capable of using mate-
paired data for metagenome scaffolding (i.e., the process through
which read pairing information is used to order and orient the
contig along a chromosome). Bambus 2 is used for the scaffolding
step of the assembly process and is compatible with the output of
most modern assemblers. Finally, among de novo assemblers
speciﬁcally implemented for metagenome assembly, we can cite
MAP (Metagenomic Assembly Program) which is developed for
Sanger and 454/Roche generated reads (Lai et al., 2012). It uses
mate pairs information to construct contigs when repeats con-
found the assembly.Genotype abundances, community diversity and structure
An application of taxonomic classiﬁcation and assembly is the
characterization of the community’s diversity and structure,
which relies on estimating the number of different genotypes in
the sample (richness) and deﬁning their relative abundances and
distribution (evenness) among the metagenomes. Simple read
counts are often erroneously used to indicate relative abunda-
nces of different genotypes or different protein families within a
metagenome. Indeed, metagenomic sequences only are a subset
of the genomic sequences present in the sample and are obtained in a
stochastic manner through high-throughput sequencing. Thus, longer
genomes have a higher probability of being sequenced. Moreover,
metagenomes usually contain high percentages of unknown
sequences, which are usually not accounted for in the results of
similarity-based taxonomic classiﬁcation methods and which,
conversely, should be considered in diversity estimates. The
problem of the accurate estimation of species’ relative abun-
dances has been addressed by the GAAS tool. GAAS (Genome
relative Abundance and Average Size) is a freely available tool
fundamentally based on the assumption that the probability that
a genome will be sequenced in a metagenomic study is directly
proportional to its length (Angly et al., 2009). Thus, it performs
sequence similarity searches and normalizes the number of reads
recovered for a speciﬁc genome to the length of that genome, thus
achieving more precise estimates. The accuracy of GAAS depends
on the frequency of the ambiguous taxonomic assignment of
reads (i.e., reads that cannot be reliably assigned to a unique
genome) as it weights hits only by E-value (Xia et al., 2011;
Lindner and Renard, 2012). The more recent GRAMMy tool
(Genome Relative Abundance estimates based on Mixture Model
theory) ﬁlters hits by E-value, alignment length and identity rate,
and it manages ambiguous read assignments in a probabilistic way
(Xia et al., 2011). It performs taxonomic assignment and computes
the probability that each read is assigned to one of the reference
genomes. Estimates of relative abundances as well as log-likelihood
and standard error are then computed by maximum likelihood
method. A different approach is implemented by GASiC (Genome
Abundance Similarity Correction) (Lindner and Renard, 2012). This
tool assumes that similarities among reference genomes are one of
the major sources of ambiguities in reads assignments. Thus it
computes abundances on the basis of reads alignments to reference
genomes and then it directly uses observations on reference
genomes similarities to correct the observed abundances. The
community structure and diversity of viral communities can be
estimated from metagenomic data using the Circonspect (Angly
et al., 2006) and PHACCS tools (Angly et al., 2005). Circonspect uses
an external assembly program and a bootstrap technique to auto-
mate the generation of the contig spectrum, which is the count of
the number of contigs of each different size in an assembly. It relies
on the assumption that the larger the contigs in the contig spectrum
are for one genotype, the higher is the number of copies and themore abundant is this genotype. Thus, a highly diverse metagenome
is supposed to produce a high number of small contigs and vice
versa for a less diverse one. The contig spectrum is used as an input
by PHACCS (PHAge Communities from Contig Spectrum) along with
the average genome size estimated by GAAS to mathematically
model the structure of viral communities and make predictions
about diversity. Indeed, because not all sequences are entirely
sequenced in a metagenomic survey, it predicts diversity by
constructing models of species’ relative abundances from available
data and then extrapolating the diversity expected at an inﬁnite
sampling effort. In this way, it gives estimates of community
richness, evenness and diversity. Interestingly, the method uses all
of the available information, i.e., both known and unknown
sequences. Indeed, it is based on the contig spectrum, which is
computed using the whole set of metagenomic sequences.
Statistical tools for the analysis of clinical metagenomic samples
Statistical considerations are essential for the correct inter-
pretation of metagenomic data in a wide range of cases, such as
accurately estimating species’ relative abundances or the com-
munity diversity. Metagenome comparisons also require statisti-
cal tests to assess the signiﬁcance of observed differences or
normalization procedures to account for the different sizes of the
compared metagenomes. Most tools in comparative metage-
nomics were speciﬁcally developed for phylogenetic comparisons
and, in particular, for 16S rRNA gene metagenomic surveys. Other
tools were then developed for random sequencing of high-
throughput data, such as ShotgunFunctionalizeR (Kristiansson et al.,
2009) for functional comparisons of metagenomes. This tool focuses
on the abundance of gene families, i.e., sets of functionally similar
genes. Changes in gene family abundances between metagenomes
can be linked to functional differences based on their corresponding
annotations. XIPE-TOTEC (Rodriguez-Brito et al., 2006) is a rapid and
user-friendly non-parametric statistical test that is designed for
pairwise comparisons. However, a common issue with these tools is
their inability to address multiple comparisons. This is an essential
task in viral metagenomics when applied to clinical research
because it relies on the comparison of two populations (patients
and controls), each comprising multiple samples. Furthermore, it
is of vital interest to precisely identify what is the statistically
signiﬁcant differential feature between the two populations
studied (patients and controls) when we aim to detect, for
example, those viruses whose presence or absence contributes
to human disease.
Recently, Metastats (White et al., 2009) and STAMP (Parks and
Beiko, 2010) have been developed to identify differentially abun-
dant features between metagenomes. Metastats has been speci-
ﬁcally implemented for clinical metagenomic sample analyses,
and it provides a robust statistical framework. Metastats nor-
malizes data to account for differences in metagenome sizes, can
be conﬁdently applied to non-normally distributed data, applies
multiple comparison corrections and handles sparse counts using
Fisher’s exact test. STAMP is another valuable tool that uses
conﬁdence intervals and effect size statistics (i.e., the magnitude
of the observed difference). Conﬁdence intervals are more infor-
mative than the more commonly used p-value. Effect size
statistics are used to assess whether a differentially abundant
feature is not only statistically signiﬁcant (as indicated by the
p-value) but also biologically relevant; arbitrarily small effects
can have statistically signiﬁcant p-values when the sample sizes
are sufﬁciently large.
These methods are of paramount interest for the detection of
differentially abundant features in clinical samples compared
with healthy controls. However, the assessment of an observed
correlation between a speciﬁc feature and the disease state is a
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complicated by the wide range of different viral genotypes
observed in many viral groups in which each genotype can be
associated or not to different symptoms. In addition, many viral
infections seem to cause symptoms only in a subset of indivi-
duals, and co-infections can further complicate the interpretation
of the results. The efﬁcacy and informativeness of the described
types of comparative analyses depend on the depths to which the
functional and/or taxonomical annotations of viral metagenomes
are performed. Although metagenome comparisons have yielded
useful information to researchers about the differences, for
example, between the viral communities associated with the
sputa of healthy individuals and cystic ﬁbrosis patients (Willner
et al., 2009), they are still based on partial views of the sampled
communities. Indeed, they do not take into consideration the
unknown metagenomic sequences, which constitute a signiﬁcant
proportion of viral metagenomes. Conversely, Maxiphi (Angly
et al., 2006) allows comparison of metagenomes at the sequence
level rather than at the annotation level so that all of the reads are
informative. Brieﬂy, this tool assembles a random subset of
sequences that equally represents each metagenome and ana-
lyzes the amount of overlap between sequences from different
metagenomes, i.e., how many sequences from one metagenome
overlap with sequences from another metagenome. The amount
of this overlap indicates the degree of similarity between the two
metagenomes. Then, it performs Monte Carlo simulations to
estimate whether the differences are due to changes in the
relative abundances of the viruses in the two metagenomes or
to the presence of fundamentally different viruses. The output is
the estimation of the ‘‘beta-diversity’’, which is based on the
percentages of species that are shared between the metagenomes
and the percentages of the permuted abundances of these species.
However, we lack tools that precisely identify the statistically
signiﬁcant differential features between two metagenomes while
considering unknown sequences in the comparison. Thus, further
efforts should be applied to this area to improve metagenome
annotation and decrease the percentage of unknown sequences.
Characterization of the ‘‘unknown’’
The ﬁrst metagenomic surveys performed on environmental
viral communities showed that more than 60% of the sequences
had no signiﬁcant similarity to sequences stored in public
databases (Edwards and Rohwer, 2005). A high percentage of
unidentiﬁable sequences, classiﬁed as ‘‘unknown,’’ are also found
in metagenomic studies on viral communities that are associated
with humans. The taxonomic identiﬁcation and functional anno-
tation of metagenomic sequences is a major problem, and until
now it has been addressed mostly through BLAST searches.
However, it is estimated that the use of existing BLAST-based
approaches for taxonomic classiﬁcation results in 10% to 90% of
sequences being returned as unknown (Huson et al., 2007).
Several factors contribute to the limited recovery rate of these
approaches: (i) the short read lengths produced by high-
throughput sequencing technologies; (ii) the incompleteness of
public sequence databases; and (iii) sequencing errors. It has been
proposed that integrating BLAST scores with information about
gene adjacency will increase the efﬁcacy of these similarity
searches (Weng et al., 2010). In this approach, unclassiﬁed contigs
or individual reads are blasted using less stringent E-values, and
all of the top 250 hits are selected and compared in a pairwise
fashion. Adjacent hits that are not consistent with the genomic
arrangement of their reference genome are discarded, and
between the remaining pairs the ones with the minimum E-value
products are selected and used for taxonal classiﬁcation of the
sequence. However, this approach is based on the evolutionaryconservation of gene order, which has been shown to be an
important feature in prokaryotes but not in viruses (Tamames
et al., 1997; Tamames, 2001).
Another approach to characterize unknown sequences by
similarity-based methods derives from research on conserved
protein domains, which are evolutionarily more conserved than
the primary sequence and which can identify more remote
similarities. Several databases of conserved protein domains exist,
including Pfam, CDD, SMART and TIGRFAM (Punta et al., 2011;
Marchler-Bauer et al., 2011; Letunic et al., 2011; Haft, 2003).
These databases are commonly explored using BLAST or HMM-
based alignments. The HMM-based alignment method has a high
sensitivity for detecting remote homologs (Karplus et al., 1998).
However, it cannot optimally classify sequences with frameshift
errors. Thus, sequencing errors, such as those produced by high-
throughput sequencing in metagenomic projects can hamper the
identiﬁcation of such domains. Recently, a new method of domain
classiﬁcation has been implemented that corrects for frameshift
translations and is more suitable to metagenomic data analysis:
HMM-FRAME (Zhang and Sun, 2011).
Another similarity-based approach for tentative sequence
identiﬁcation is phylogenetic analysis. This approach is based on
the assumption that unknown genes, which are true remote
homologs of known genes, should group with them in a phylo-
genetic tree. The construction of a phylogenetic tree for each
unidentiﬁable sequence is rather inaccessible and time consum-
ing for biologists without bioinformatics expertise. Thus, a user-
friendly automated pipeline has been developed for the construc-
tion of multiple phylogenetic trees: Phylogena (Hanekamp et al.,
2007). This tool allows automatic phylogenetic annotation of
unknown sequences through an automated BLAST search of
homologous sequences followed by the choice of a representative
subset, computation of multiple alignments and construction of
the phylogenetic tree. Still, this approach relies on the presence of
(remote) homologs of the sequence in public databases and
cannot be applied to highly divergent sequences. A radically
different approach, independent from sequence similarity, is the
use of composition-based methods for taxonomic classiﬁcation,
already cited in this review, which does not depend on the
presence of homologs in public databases.
No more speciﬁc in silico methods are available, to our knowl-
edge, for the characterization of unknown sequences. Some wet-
lab experiments can be performed at this point, such as the
cloning and expression of the unknown putative coding
sequences followed by the characterization of the encoded
protein’s three-dimensional structure. Alternatively, it could be
useful to study the metabolic function of the sequence by
expressing it in Escherichia coli and observing the bacteria’s
growth in a chemostat culture. Recently, the cloning of sequences
from a human gut microbiome and gulls metagenomes completed
by an antibiotic resistance screening of the clones has allowed
identifying several uncharacterized genes as antibiotic-resistance
genes (Sommer et al., 2009; Martiny et al., 2011). However, given
the large amount of unknown putative encoding sequences, the
wet-lab approach is not an economical approach for characteriz-
ing all of them. Further in silico tools are thus needed to perform
this task.
Next-generation sequencing technologies and the need for a common
standardized pipeline analysis
The metagenomic ﬁeld evolves in parallel with the develop-
ment of sequencing technologies. The ﬁrst metagenomic studies
were based on Sanger sequencing, which yielded reads of
approximately 800 bp. Later, the so-called ‘‘next-generation’’
sequencing (NGS) technologies were developed, which are
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complete picture of the community and allowing discrimination
between different sub-populations within the same sample. The
ﬁrst and still most used NGS platform is Roche/454 sequencing
(Margulies et al., 2005). Recently, NGS such as ABI/SOLiD (Applied
Biosystems by Life Technologies), the SMRT sequencing (Paciﬁc
Biosciences) and Illumina/Solexa (Bennett, 2004) which have
even higher throughputs in comparison to Roche/454, have
appeared. The SOLiD technology generates reads as short as 50
bp; thus, at the current state of the art, it is not used for
metagenomic studies but only for whole genome re-sequencing
(where deep sequencing allows correction of sequencing errors
and detection of subpopulations) or RNA-sequencing projects.
The single-molecule real-time (SMRT) sequencing technology
was developed by Paciﬁc Biosciences in 2009 (Eid et al., 2009). In
principle, it should allow to reach average read lengths as high as
3000 bp with instances of over 10,000 bp. However, accuracy of
single reads is only at 85% which, up to now, makes the
technology unusable in its current form for metagenomic applica-
tions. Illumina/Solexa technology, instead has already been
successfully employed both in 16S rRNA metagenomic surveys
on bacterial communities and in viral metagenomic projects
(Greninger et al., 2010). It generates reads of about 100–150 bp
and an output of up to 600 Gb per run. Its capacity to identify
known and unknown viruses in biological samples has been
compared to that of the Roche/454 platform in a blind metage-
nomic study on samples artiﬁcially spiked with viruses (Cheval
et al., 2011). The results showed higher sensitivity for the
detection of known viruses for the Illumina technology, which is
most likely due to its considerably higher output compared to
Roche/454. Conversely, Roche/454 sequencing performed better
at the identiﬁcation of unknown viruses because it generates
longer reads, which allow easier assembly of de novo contigs of
sufﬁcient size to suggest the presence of a new virus.
The development of adapted bioinformatics tools still consti-
tutes a bottleneck for the spread of the Illumina technology in the
ﬁeld of viral metagenomics. Most bioinformatics tools for meta-
genomic analyses were optimized for pyrosequencing-generated
sequences and are not suitable for Illumina-generated reads
whose shorter lengths complicate the taxonomic assignment of
the reads and the assembly task. Moreover, we still need addi-
tional tools to routinely assemble or compare and combine data
sets from different kinds of sequencing technologies, such as the
recent Segminator II (Archer et al., 2012) and ngs_backbone
softwares (Blanca et al., 2011).Conclusions
The ﬁeld of bioinformatics for metagenomics is very dynamic
and new programs are continuously being created to manage the
new NGS-generated data. Initial metagenomic studies used sev-
eral tools previously developed for single genomic projects.
However, it has become evident that metagenomics brings
speciﬁc issues which have to be addressed by speciﬁc or adapted
algorithms. Analyses that may be common with single genomics
projects still present some speciﬁc issues when performed on
metagenomic data. For instance, the assembly of a metagenome
may be challenged by the presence of sequences from different
organisms that share some genomic regions, further leading to
the in silico generation of chimeric contigs. New assemblers have
thus been speciﬁcally developed for metagenomic studies. In
addition, some issues are speciﬁc to the nature of studied
community (viruses, bacteriay). Hence, the computational tools
developed initially for bacterial metagenomics may not be applic-
able to viral metagenomics and this is particularly true in theannotation ﬁeld. Fig. 1 reports examples of tools developed for
each step of a metagenomic analysis and the speciﬁc issues
(if any) which have to be addressed in metagenomics (with
emphasis on viral metagenomics). Indeed, a variety of different
programs can be adapted for metagenomic analyses and fre-
quently small in-house scripts are required. Presently, no com-
mon strategies have been established for the analysis of viral
metagenomes and no universal standard parameters exist for
assembly, BLAST searches or the quality trimming of reads. All of
these factors make viral metagenomic analyses difﬁcult to com-
pare and difﬁcult to reproduce. Standardization and coordination
of efforts to analyze viral communities that are associated with
humans are needed, which have already been undertaken in the
Human Microbial Project for bacterial communities. In this view,
although no completely exhaustive databases exist for viral
metagenome submission and analysis, some platforms have been
developed that allow for storage, public access and analysis of
metagenomes, such as MetaVir (Roux et al., 2011) and VIROME
(Wommack et al., 2012) and VMGAP (Viral MetaGenome Annota-
tion Pipeline) for functional annotation (Lorenzi et al., 2011). Such
initiatives constitute valuable ﬁrst efforts towards data sharing
and analysis standardization.Acknowledgments
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